Intranasal administration of nanoemulsion of naringenin accompanied by levodopa played an essential role in the amelioration of behavioral parameters, increment of GSH and SOD, as well as decrement of MDA level in 6-OHDA-induced PD in rats. This evidence concerns the gene SOD1 and Parkinson disease.